Table 1 Demographics and other characteristics by year of serum collection (N = 7576)
1992 (n = 3081) | 2000 (n = 3000) | 2008 (n = 2996) | |
|---|---|---|---|
Age–mean [std] | 26.6 [19.9] | 26.4 [20.1] | 26.1 [21.0] |
Sex–n (%) | |||
Male | 1476 (47.9) | 1500 (50.0) | 1497 (50.0) |
Female | 1605 (52.1) | 1500 (50.0) | 1499 (50.0) |
KSHV serostatus1–n (%) | |||
Negative | 286 (9.3) | 180 (6.0) | 312 (10.4) |
Positive | 2795 (90.7) | 2820 (94.0) | 2684 (89.6) |
EBV serostatus2–n (%) | |||
Negative | 205 (6.7) | 149 (5.0) | 200 (6.7) |
Positive | 2876 (93.3) | 2851 (95.0) | 2796 (93.3) |
HIV serostatus–n (%) | |||
Negative | 2868 (93.1) | 2687 (89.6) | 2750 (91.8) |
Positive | 190 (6.2) | 184 (6.1) | 192 (6.4) |
CD4 T cell count (per mm3)3–mean [std] | 898 [428] | 931 [851] | 638 [353] |
WHO HIV disease stage4–n (%) | |||
1 (asymptomatic/acute retroviral syndrome) | 24 (32.0) | 22 (17.9) | 23 (16.4) |
2 | 23 (30.7) | 25 (20.3) | 41 (29.3) |
3 | 21 (28.0) | 64 (52.0) | 59 (42.1) |
4 (most severe disease) | 7 (9.3) | 12 (9.8) | 17 (12.1) |